Onyx Pharmaceuticals
company
About
Onyx Pharmaceuticals is a biopharmaceutical company committed to improving the lives of people with cancer.
- 101 - 250
Highlights
Details
- Last Funding Type
- Seed
- Industries
- Biotechnology,Medical
- Founded date
- Jan 1, 1992
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Onyx Pharmaceuticals is a biopharmaceutical company committed to improving the lives of people with cancer. Their lead product is Nexavar (sorafenib), a novel, oral multiple kinase inhibitor that targets proteins involved in both tumor cell proliferation and angiogenesis.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Onyx Pharmaceuticals has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 1993 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 1993 | Seed | — | 1 |
Sequoia Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Onyx Pharmaceuticals is funded by 1 investors.
Sequoia Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Sequoia Capital
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
